June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Aptevo Therapeutics (APVO) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 15, 2025 (23:39)
Sector: HealthcareThe share price of Aptevo Therapeutics Inc. (APVO) now
Are you interested in Aptevo Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aptevo Therapeutics stock price in 2025, 2026, 2027. How much will one Aptevo Therapeutics share be worth in 2025 - 2027?
When should I take profit in Aptevo Therapeutics stock? When should I record a loss on Aptevo Therapeutics stock? What are analysts' forecasts for Aptevo Therapeutics stock? What is the future of Aptevo Therapeutics stock? We forecast Aptevo Therapeutics stock performance using neural networks based on historical data on Aptevo Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aptevo Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aptevo Therapeutics shares. This happens once a day.
Historical and forecast chart of Aptevo Therapeutics stock
The chart below shows the historical price of Aptevo Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Aptevo Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targets CD123 and CD3 and redirects T-cell cytotoxicity to the tumor; ALG.APV-527, for the treatment of a broad spectrum of cancers over-expressing the 5T4 tumor antigen, including mesothelioma, non-small-cell-lung, head & neck, pancreatic, renal, ovarian, and bladder cancers; and APVO603.
Aptevo Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun 17 | 3.87 | 3.73 | 4.17 | 11.79 |
| Jun 18 | 3.62 | 3.18 | 3.87 | 21.72 |
| Jun 19 | 3.57 | 3.34 | 3.97 | 18.80 |
| Jun 20 | 3.69 | 3.37 | 3.82 | 13.11 |
| Jun 21 | 3.84 | 3.60 | 4.05 | 12.65 |
| Jun 22 | 4.45 | 4.17 | 4.68 | 12.12 |
| Jun 23 | 4.15 | 3.64 | 4.62 | 27.01 |
| Jun 24 | 4.47 | 4.07 | 4.93 | 21.27 |
| Jun 25 | 4.67 | 4.11 | 5.08 | 23.64 |
| Jun 26 | 5.03 | 4.72 | 5.50 | 16.55 |
| Jun 27 | 5.15 | 4.68 | 5.45 | 16.55 |
| Jun 28 | 5.97 | 5.61 | 6.41 | 14.31 |
| Jun 29 | 5.88 | 5.56 | 6.14 | 10.32 |
| Jun 30 | 6.42 | 5.70 | 7.17 | 25.77 |
| Jul 01 | 7.45 | 6.66 | 7.71 | 15.74 |
| Jul 02 | 8.22 | 7.71 | 8.70 | 12.80 |
| Jul 03 | 8.71 | 8.36 | 9.70 | 16.00 |
| Jul 04 | 8.57 | 8.13 | 8.94 | 9.95 |
| Jul 05 | 8.83 | 7.77 | 9.52 | 22.55 |
| Jul 06 | 8.48 | 8.18 | 9.40 | 14.93 |
| Jul 07 | 8.50 | 7.77 | 9.32 | 19.96 |
| Jul 08 | 8.95 | 8.51 | 9.74 | 14.48 |
| Jul 09 | 9.20 | 8.70 | 10.17 | 16.92 |
| Jul 10 | 8.80 | 8.41 | 9.63 | 14.57 |
| Jul 11 | 9.52 | 8.79 | 9.91 | 12.83 |
| Jul 12 | 9.99 | 9.32 | 10.57 | 13.38 |
| Jul 13 | 10.04 | 9.14 | 10.50 | 14.94 |
| Jul 14 | 9.35 | 8.97 | 10.26 | 14.33 |
| Jul 15 | 8.20 | 7.20 | 8.64 | 20.04 |
| Jul 16 | 8.22 | 7.41 | 9.09 | 22.74 |
Aptevo Therapeutics Daily Price Targets
Aptevo Therapeutics Stock Forecast 06-17-2025.
Forecast target price for 06-17-2025: $3.87.
Negative dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 10.550%.
Pessimistic target level: 3.73
Optimistic target level: 4.17
Aptevo Therapeutics Stock Forecast 06-18-2025.
Forecast target price for 06-18-2025: $3.62.
Negative dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 17.841%.
Pessimistic target level: 3.18
Optimistic target level: 3.87
Aptevo Therapeutics Stock Forecast 06-19-2025.
Forecast target price for 06-19-2025: $3.57.
Negative dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 15.827%.
Pessimistic target level: 3.34
Optimistic target level: 3.97
Aptevo Therapeutics Stock Forecast 06-20-2025.
Forecast target price for 06-20-2025: $3.69.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 11.592%.
Pessimistic target level: 3.37
Optimistic target level: 3.82
Aptevo Therapeutics Stock Forecast 06-21-2025.
Forecast target price for 06-21-2025: $3.84.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 11.229%.
Pessimistic target level: 3.60
Optimistic target level: 4.05
Aptevo Therapeutics Stock Forecast 06-22-2025.
Forecast target price for 06-22-2025: $4.45.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 10.807%.
Pessimistic target level: 4.17
Optimistic target level: 4.68
APVO (APVO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 16.65 | -90.12 | 75.30 | 219.67 |
| Aug. | 9.13 | -51.91 | 52.03 | 199.76 |
| Sep. | -13.14 | -79.57 | 24.82 | 420.53 |
| Oct. | -43.98 | -357.71 | 186.36 | 291.95 |
| Nov. | -123.41 | -881.16 | 155.18 | 667.82 |
| Dec. | 222.04 | -1 041.14 | 1 084.21 | 196.03 |
Aptevo Therapeutics forecast for this year
Aptevo Therapeutics Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $16.654. Pessimistic: $-90.12. Optimistic: $75.30
Aptevo Therapeutics Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $9.13475. Pessimistic: $-51.91. Optimistic: $52.03
Aptevo Therapeutics Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $-13.1367. Pessimistic: $-79.57. Optimistic: $24.82
Aptevo Therapeutics Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $-43.979. Pessimistic: $-357.71. Optimistic: $186.36
Aptevo Therapeutics Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $-123.405. Pessimistic: $-881.16. Optimistic: $155.18
Aptevo Therapeutics Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $222.043. Pessimistic: $-1 041.14. Optimistic: $1 084.21
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 803.51 | -3 114.55 | 5 592.24 | 155.69 |
| Feb | -357.40 | -1 841.96 | 1 417.62 | 229.93 |
| Mar | -228.31 | -1 836.36 | 905.58 | 302.78 |
| Apr | -764.33 | -2 834.88 | 3 997.95 | 170.91 |
| May | -5.12 | -35.64 | 23.55 | 251.35 |
| Jun | -7.43 | -24.88 | 37.54 | 166.29 |
| Jul | 16.06 | -76.75 | 100.17 | 176.62 |
| Aug | 39.26 | -184.09 | 166.89 | 210.31 |
| Sep | 170.44 | -198.94 | 1 001.53 | 119.86 |
| Oct | 1 709.50 | -9 868.07 | 8 347.30 | 218.22 |
| Nov | 11 589.00 | -14 573.20 | 35 658.30 | 140.87 |
| Dec | -29 224.00 | -177 004.00 | 160 779.00 | 210.09 |
Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | -140 059.00 | -519 479.00 | 745 254.00 | 169.70 |
| Feb | 846 433.00 | -4 121 710.00 | 4 897 380.00 | 184.16 |
| Mar | 693 567.00 | -2 813 660.00 | 4 075 540.00 | 169.04 |
| Apr | -2 437 890.00 | -17 847 800.00 | 4 386 490.00 | 506.88 |
| May | 13 192 100.00 | -65 430 400.00 | 78 711 000.00 | 183.13 |
| Jun | -1 102 860.00 | -7 675 710.00 | 3 776 980.00 | 303.22 |
| Jul | 789 319.00 | -636 192.00 | 5 636 060.00 | 111.29 |
| Aug | 2 713 760.00 | -15 420 100.00 | 15 946 600.00 | 196.70 |
| Sep | 508 287.00 | -1 006 360.00 | 4 180 150.00 | 124.07 |
| Oct | 2 573 710.00 | -2 074 410.00 | 16 053 300.00 | 112.92 |
| Nov | -3 468 850.00 | -26 961 600.00 | 7 494 450.00 | 459.75 |
| Dec | 17 518 000.00 | -97 959 100.00 | 136 159 000.00 | 171.94 |
Aptevo Therapeutics information and performance
2401 4TH AVE., SUITE 1050, SEATTLE, WA, US
Market capitalization of the Aptevo Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of APVO shares in the company outstanding by the market price of one share.
EBITDA of Aptevo Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Aptevo Therapeutics (APVO) stock dividend
Aptevo Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 03/27/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
FAQ (Frequently Asked Questions about Aptevo Therapeutics Stock)
Should I Buy Aptevo Therapeutics Shares in 2025 year?
Does Aptevo Therapeutics pay dividends?
Which economic sector do Aptevo Therapeutics's shares belong to?
Which other securities belong to the same sector as Aptevo Therapeutics's shares?
